Stocks and Investing
by (remove) : David Risinger
RSSJSONXMLCSV
Stocks and Investing
by (remove) : David Risinger
RSSJSONXMLCSV
Tue, August 6, 2024
Wed, July 24, 2024
Tue, April 16, 2024
Wed, October 11, 2023
Mon, July 10, 2023
Fri, February 10, 2023
Wed, February 8, 2023
Thu, February 2, 2023
Tue, January 17, 2023
Thu, December 22, 2022
Thu, November 17, 2022
Fri, September 30, 2022
Mon, May 23, 2022
Fri, April 30, 2021
Wed, March 10, 2021
Fri, February 26, 2021
Thu, January 28, 2021
Fri, November 13, 2020
Thu, August 20, 2020
Mon, May 11, 2020
Thu, April 2, 2020
Wed, April 1, 2020
Fri, February 14, 2020

David Risinger Downgraded (TBPH) to Hold and Decreased Target to $10 on, Aug 6th, 2024


Published on 2024-10-28 13:14:53 - WOPRAI, David Risinger
  Print publication without navigation


David Risinger of Leerink Partners, Downgraded "Theravance Biopharma, Inc." (TBPH) to Hold and Decreased Target from $15 to $10 on, Aug 6th, 2024.

David has made no other calls on TBPH in the last 4 months.



There is 1 other peer that has a rating on TBPH. Out of the 1 peers that are also analyzing TBPH, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $21 on, Friday, April 12th, 2024
Contributing Sources